Functional gastrointestinal disorders range from highly prevalent, but generally benign conditions, eg, functional dyspepsia and irritable bowel syndrome, to rare and potentially life-threatening diseases, eg, intestinal pseudo-obstruction syndromes. The term…
Gastrointestinal motility can be markedly deranged in critical illness. This can have a number of important clinical sequelae—the most obvious of which is impaired delivery of enteral nutrition, which can…
Gastrointestinal (GI) symptoms occur commonly in patients with cancer and may reflect dysfunction throughout the gut ( Box 1 ). Many potential causes exist for these symptoms including GI dysmotility….
Down Syndrome Down syndrome (DS) is the most common chromosomal abnormality occurring in humans. In Europe, DS accounts for 8% of all registered cases of congenital anomalies. Throughout the world,…
As populations age, the prevalence of neurologic disease in the community continues to increase, and consultations relating to gastrointestinal motility problems in the patient afflicted with a neurologic disorder become…
Gastrointestinal motility disorders affect the neuromuscular functions needed for movement of contents through the gastrointestinal tract. This definition excludes strictures and other mechanical causes for impaired passage from the concept…
This issue of Gastroenterology Clinics of North America is focused on challenges faced in everyday clinical practice. Thus rather than reviewing the evolving research literature that details the many experimental…
Eamonn M.M. Quigley, MD, FRCP, FRCPI Guest Editor The study of gastrointestinal motility and those disorders that result from its disordered function has, for far too long, been a much…
Pancreatic ductal adenocarcinoma comprises more than 90% of pancreatic tumors. It is the 10th most common cancer diagnosis in the United States, but represents the fourth most common cause of…
Pancreatic adenocarcinoma is the fourth leading cause of cancer death in the United States, with a 5-year survival rate of 5.6%. One third of pancreatic cancer patients have local or…
